Technology Transfer happens when a pharmaceutical company wants to establish a new manufacturing facility and/or change from an existing manufacturing site to a new manufacturing site. A strategic investment in technology transfers results in manufacture high quality products and long-term cost savings. Whether it’s for scaling-up or establishing new facility, technology transfers are part of the normal course of our business. Led by a professional expert panel of experienced Scientists, SPC Services has the power to make your therapeutic molecule vision a reality – from pre-clinical studies through commercial supply. We provide services for your needs from development, approval, licencing and mass production of pharmaceutical and biopharmaceutical products including the following fields:
TECHNOLOGY TRANSFER
BIOPHARMACEUTICALS and BIOSIMILARS
Biosimilars are biological medical products that are almost identical copy of original products that are manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products and can be manufactured when the original product’s patent expires and there are no clinically meaningful differences in terms of safety, purity, and potency. Taking into account that SPC experts have been involved or the initiators of different biosimilars, we can provide all necessary technical information, consultation and documentation to our clients for production of high standard biosimilars.
HUMAN & VETERINARY VACCINES
The market of veterinary medicine is becoming of great interest to many investors. The major factors responsible for the growth of the veterinary medicine market are the increasing burden of chronic diseases among animals, growing animal adoption, and the increase in drug preferences by pet and poultry farm owners, coupled with continued growth in the human population, leading to increased demand for meat and animal-based products. SPC will be more than happy to provide its clients for manufacturing of different classes of veterinary products both generics and biosimilars.
THRAPEUTIC SERA
Swiss is the country of peace, respect and standards. Inspired by the soul of our country, we adhere to the highest standards in providing any services to our costumes, in our relations with our partners, and in every other aspects of our business. We highlight Swiss origin of SPC both in our organizational culture and when introducing our company and services, to emphasize our commitment to be a true representative of the globally recognized values of our nation, including peacefulness, happiness, trust, and humanitarianism.
DIAGNOSTIC KITS
Excellence is the core value shaping the quality of SPC’s services delivery. We believe our costumers deserve nothing less than the best in every services they request us to provide. Doesn’t matter it be the transferring a high-level technology, tackling CDMO-based manufacturing of a product, training of their managers and stuff, or exporting equipment and ingredients, we are firmly committed to find the best quality pathways and formulate the best solutions, maximizing the benefits of our customers. The same holds true in our relationship with our partners, where not only do we select our closely working partners from among the bodies adherent to the principles of excellency, but we strive to foster a corporate excellence culture together with our partners enabling the best practice in services delivery.
VETERINARY MEDICINE
The market of veterinary medicine is becoming of great interest to many investors. The major factors responsible for the growth of the veterinary medicine market are the increasing burden of chronic diseases among animals, growing animal adoption, and the increase in drug preferences by pet and poultry farm owners, coupled with continued growth in the human population, leading to increased demand for meat and animal-based products. SPC will be more than happy to provide its clients for manufacturing of different classes of veterinary products both generics and biosimilars.
FOOD SUPPLEMENTS
Food or nutritional supplements are used as an addition to a normal diet or even a supplement or replacement to many medicines. Food business operators market food supplements, which are concentrated sources of nutrients (or other substances) with a nutritional or physiological effect. Due to their natural sources and minimal or lack of adverse effects, there is a high demand to use these products, hence it has become a lucrative business in food and pharmaceutical industry. SPC can therefore offer its expertise to the investors who would like to establish such industry.
HERBAL MEDICINE
Herbal medicines are products developed and manufactured from botanicals, or plants, that are used to treat diseases or to maintain health. They are called herbal products, botanical products, or phytomedicines. These days, many prescription drugs and over-the-counter medicines are also made from plant products and therefore due to nature and also much less side effects are replacing chemical drugs. Fortunately, two of SPC partner companies have a long experience in production of herbal medicines that can offer to our clients.
COSMETICS
The global market size of cosmetics was valued at US$ 341.1 billion in 2020 and is expected to be worth US$ 480.4 billion by 2030 with a compound annual growth rate (CAGR) of 5.1% from 2021 to 2030. On the other hand, the regulatory process for production and sale of cosmetics are much less strict, compared to vaccines and pharmaceutical product. According to its status, development, production and marketing of cosmetics constitute a major activity of SPC, among other pharmaceutical products.
